肝门部胆管癌诊断和治疗指南(2025版)  

Guideline for diagnosis and treatment of perihilar cholangiocarcinoma(2025 edition)

作　　者：中国研究型医院学会肝胆胰外科专业委员会 《中华消化外科杂志》编辑委员会 董家鸿[2] 李相成 项灿宏[4] 陈敏 赵蕾 白志清 张耀东 Society for Hepato-pancreato-biliary Surgery of Chinese Research Hospital Association;Editorial Board of Chinese Journal of Digestive Surgery;Dong Jiahong;Li Xiangcheng;Xiang Canhong;Chen Min(不详;Institute for Precision Medicine,School of Clinical Medicine,Tsinghua University,Beijing 102218,China;Hepatobiliary Center,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Hepato-pancreato-biliary Surgery,Beijing Tsinghua Changgung Hospital,Tsinghua University,Beijing 102218,China;Department of Hepatobiliary Surgery,The First Hospital Affiliated to Army Medical Hospital,Chongqing 400038,China;Editorial Board of Chinese Journal of Digestive Surgery)

机构地区：[1]不详 [2]清华大学临床医学院、清华大学精准医学研究院,北京102218 [3]南京医科大学第一附属医院肝胆中心,南京210029 [4]清华大学附属北京清华长庚医院肝胆胰中心,北京102218 [5]陆军军医大学第一附属医院全军肝胆外科,重庆400038 [6]《中华消化外科杂志》编辑委员会 [7]陆军军医大学第一附属医院 [8]清华大学附属北京清华长庚医院 [9]清华大学临床医学院 [10]南京医科大学第一附属医院

出　　处：《中华消化外科杂志》2025年第1期1-20,共20页Chinese Journal of Digestive Surgery

基　　金：国家自然科学基金(92359301,82472865,82273066,82027807);中国科技期刊卓越行动计划(卓越二期-B1-090)。

摘　　要：肝门部胆管癌是胆道恶性肿瘤的常见类型。肝门部胆管癌的诊疗涉及流行病学、临床诊断、影像学检查、临床分型分期、病理学、可切除性评估、围手术期管理、手术抉择、系统治疗以及随访监测等多个环节,是肝胆外科中诊疗难度最大、技术要求最高的领域之一。为指导我国肝门部胆管癌诊疗更规范、安全、有效地开展,中国研究型医院学会肝胆胰外科专业委员会和《中华消化外科杂志》编辑委员会组织全国肝门部胆管癌领域的专家共同制订《肝门部胆管癌诊断和治疗指南(2025版)》,旨在基于最新临床实践与循证医学原则,提供肝门部胆管癌的规范化诊断与治疗方案,以提升诊疗水平并改善患者预后,为我国开展肝门部胆管癌治疗的外科医师提供科学指导和参考。Perihilar cholangiocarcinoma is the common type of malignant tumor in the biliary tract.The diagnosis and treatment of perihilar cholangiocarcinoma involve multiple aspects such as epidemiology,clinical diagnosis,imaging examination,clinical classification and staging,pathology,resectability evaluation,perioperative management,surgical planning,systematic treat-ment,and follow-up monitoring,which make it as one of the difficult and technically demanding fields in hepatobiliary surgery.In order to guide the more standardized,safe,and effective treatment of hilar cholangiocarcinoma in China,the Society for Hepato-pancreato-biliary Surgery of Chinese Research Hospital Association and Editorial Board of Chinese Journal of Digestive Surgery have organized experts in the field of hilar cholangiocarcinoma nationwide to develop the Guideline for diagnosis and treatment of hilar cholangiocarcinoma(2025 edition).The aim is to provide standardized diagnosis and treatment plans for perihilar cholangiocarcinoma based on the latest clinical practice and evi-dence-based medicine principles,to improve diagnosis and treatment levels and patient prognosis,and to provide scientific guidance and reference for surgeons in China.

关 键 词：肝门部胆管癌 诊断 治疗 规范 指南 

分 类 号：R735.8[医药卫生—肿瘤]